All questions are shown as received by the Trust.
In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens? If possible, please also provide the split of metastatic vs non-metastatic patients for each regimen.
Regimens
Capecitabine
CAPIRI
CAPOX
Cetuximab with FOLFIRI
Cetuximab with FOLFOX
Cetuximab as a single agent
Cetuximab with Encorafenib
Irinotecan as a single agent
FOLFIRI
FOLFOX
Fluorouracil (5FU) as a single agent
Oxaliplatin as a single agent
Nivolumab with Ipilimumab
Panitumumab with FOLFIRI
Panitumumab with FOLFOX
Panitumumab as a single agent
Pembrolizumab
Any other systemic anti-cancer therapy
Palliative care only
